KENNEDY SPACE CENTER, Fla. March 6, 2020 (ISS National Lab PR) – What if the next breakthrough to improve patient care on Earth came from research off of Earth—in space? Three biotechnology startups have launched research to the International Space Station (ISS) U.S. National Laboratory, tackling a broad range of patient care objectives—from next-generation diagnostic tools to drug discovery and improved devices for drug delivery.
BOSTON, MA. (November 7, 2016)– The Center for the Advancement of Science in Space (CASIS) and Boeing awarded three research companies financial support last week through MassChallenge™. This marks the third year CASIS and Boeing have collaborated on the “Technology in Space” prize through the MassChallenge Boston Accelerator.
CASIS is the nonprofit organization responsible for managing and promoting research onboard the International Space Station (ISS) U.S. National Laboratory. Boeing is the ISS prime contractor responsible for sustaining operations, including the successful integration of vehicle and payload hardware and software for the orbiting laboratory. The grant prizes for this collaboration will provide seed funding for the three awarded companies and assist with hardware costs for flight to the ISS National Lab.